The 2nd International Congress on Clinical Trials on Cannabis (CT-Cann 2023) is dedicated to inform participants of the latest evidence and concepts regarding cannabinoid therapy, aid prescribers.
Topics
Pharamacokinetics and pharmacodynamics of cannabinoids
How can we predict the response to cannabinoid treatment?
Phytocannabinoid study – strains, chemovars, entourage and molecules
New and emerging designs for cannabis clinical trials
Clinical cannabinoid therapy across medical specialties such as Pain, Gastroenterology, Palliative Care, Psychiatry and Neurology
How to interpret clinical, observational and epidemiological studies: findings, interpretations, applicability
Clinical Registries from around the globe – what can we learn?
Cannabinoid trial best conduct including GCP and site training
Regulatory, licensing, and legal considerations – effects on clinical availability and industry development
National and international guidelines
Assessing safety and adverse events of cannabinoid medications
Translating Current Evidence to Clinical Practice
Where is the industry heading? A discussion with leaders in the field
Who should Attend
Medical professionals
Clinical Trial specialists
Researchers
General Practitioners
Trialists
Clinicians
Medical professionals
Methodologists
The European Medical Agency
Industry professionals The European Monitoring Centre for Drugs and Drug Addiction
National cannabis agencies
Past Events
The 2nd International Congress on Clinical Trials on Cannabis (CT-Cann 2023) - 15-16 Feb 2023, Hilton London Canary Wharf hotel, United Kingdom (97823)
Important
Please, check "The International Congress on Clinical Trials on Cannabis (CT-Cann)" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Alternative medicine, Family medicine, Mental Health, Neurology, Pain
